Mitsubishi UFJ Asset Management Portfolio holdings
AUM
$125B
1-Year Return
23.89%
This Quarter Return
+13.47%
1 Year Return
+23.89%
3 Year Return
+93.04%
5 Year Return
+163.06%
10 Year Return
+400.91%
AUM
$125B
AUM Growth
+$16.6B
(+15%)
Cap. Flow
+$6.52B
Cap. Flow
% of AUM
5.21%
Top 10 Holdings %
Top 10 Hldgs %
32.89%
Holding
1,656
New
55
Increased
781
Reduced
192
Closed
41
Top Buys
| 1 |
Microsoft
MSFT
|
+$579M |
| 2 |
NVIDIA
NVDA
|
+$465M |
| 3 |
Apple
AAPL
|
+$381M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$364M |
| 5 |
Zoetis
ZTS
|
+$311M |
Top Sells
| 1 |
Becton Dickinson
BDX
|
+$351M |
| 2 |
UnitedHealth
UNH
|
+$319M |
| 3 |
Revvity
RVTY
|
+$312M |
| 4 |
Hologic
HOLX
|
+$263M |
| 5 |
IQVIA
IQV
|
+$252M |
Sector Composition
| 1 | Technology | 33.37% |
| 2 | Financials | 15.51% |
| 3 | Consumer Discretionary | 10.13% |
| 4 | Healthcare | 9.37% |
| 5 | Communication Services | 9.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
951
BioNTech
BNTX
$24.7B
| $247K | ﹤0.01% |
2,321
-173
| -7% | -$18.4K |
|
952
Krystal Biotech
KRYS
$4.2B
| $247K | ﹤0.01% |
1,795
+303
| +20% | +$41.7K |
|
953
Ultragenyx Pharmaceutical
RARE
$3.04B
| $247K | ﹤0.01% |
6,783
+441
| +7% | +$16K |
|
|
LX
954
LexinFintech Holdings
LX
$1.01B
| $244K | ﹤0.01% |
33,910
-12,296
| -27% | -$88.7K |
|
955
Blue Owl Capital
OWL
$11.7B
| $240K | ﹤0.01% |
12,469
-37,419
| -75% | -$719K |
|
956
Wave Life Sciences
WVE
$1.21B
| $235K | ﹤0.01% |
36,097
+17,424
| +93% | +$113K |
|
|
BITF
957
Bitfarms
BITF
$879M
| $233K | ﹤0.01% |
277,853
+144,593
| +109% | +$121K |
|
958
Repay Holdings
RPAY
$509M
| $233K | ﹤0.01% |
48,330
+20,417
| +73% | +$98.4K |
|
959
Arrowhead Research
ARWR
$3.76B
| $232K | ﹤0.01% |
14,702
+226
| +2% | +$3.57K |
|
960
Paymentus
PAY
$4.48B
| $231K | ﹤0.01% |
7,061
-1,141
| -14% | -$37.4K |
|
961
Euronet Worldwide
EEFT
$3.59B
| $231K | ﹤0.01% |
2,278
-421
| -16% | -$42.7K |
|
962
Xencor
XNCR
$600M
| $231K | ﹤0.01% |
29,371
+17,773
| +153% | +$140K |
|
963
Immersion
IMMR
$231M
| $229K | ﹤0.01% |
29,054
-36,823
| -56% | -$290K |
|
964
Arbutus Biopharma
ABUS
$784M
| $227K | ﹤0.01% |
73,543
-2,488
| -3% | -$7.69K |
|
965
Beam Therapeutics
BEAM
$2.02B
| $226K | ﹤0.01% |
13,300
+2,808
| +27% | +$47.8K |
|
|
HIVE
966
HIVE Digital Technologies
HIVE
$687M
| $224K | ﹤0.01% |
124,450
+55,141
| +80% | +$99.3K |
|
|
CLDT
967
Chatham Lodging
CLDT
$359M
| $217K | ﹤0.01% |
31,108
| – | – |
|
968
uniQure
QURE
$960M
| $215K | ﹤0.01% |
+15,420
| New | +$215K |
|
969
Paysafe
PSFE
$837M
| $215K | ﹤0.01% |
17,026
+4,711
| +38% | +$59.5K |
|
970
Ionis Pharmaceuticals
IONS
$10.3B
| $213K | ﹤0.01% |
5,398
-737
| -12% | -$29.1K |
|
971
Deluxe
DLX
$875M
| $213K | ﹤0.01% |
13,378
+5,504
| +70% | +$87.6K |
|
972
Iovance Biotherapeutics
IOVA
$858M
| $213K | ﹤0.01% |
123,598
+91,199
| +281% | +$157K |
|
973
Avidity Biosciences
RNA
$6.18B
| $212K | ﹤0.01% |
7,461
+1,326
| +22% | +$37.7K |
|
974
Forum Energy Technologies
FET
$312M
| $208K | ﹤0.01% |
+10,673
| New | +$208K |
|
975
Bitdeer Technologies
BTDR
$2.96B
| $207K | ﹤0.01% |
+17,997
| New | +$207K |
|